Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycloset in Diabetic Autonomic Neuropathy
NCT02682901Phase 4Completed
- Sponsor
- Eastern Virginia Medical School
- Start
- Oct 2015
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bromocriptine in diabetic autonomic neuropathy (DAN), sponsored by Eastern Virginia Medical School. Started Oct 2015; status: completed.
02
Drugs
bromocriptine
03
Conditions
diabetic autonomic neuropathy (DAN)
Beyond the preview
Go deeper on NCT02682901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682901.